Search research articles
Contact Us
Filters
Showing results (391-400 of 578) with videos related to
Page
of 58
Sort By:
Cells
|
April 26, 2024
Development and Characterisation of a New Patient-Derived Xenograft Model of AR-Negative Metastatic Castration-Resistant Prostate Cancer
Daniel J Turnham, Manisha S Mullen, Nicholas P Bullock, et al.
Oncotarget
|
October 27, 2017
[10]-gingerol induces apoptosis and inhibits metastatic dissemination of triple negative breast cancer <i>in vivo</i>
Ana Carolina B M Martin, Angelina M Fuzer, Amanda B Becceneri, et al.
Molecular Cancer Therapeutics
|
August 20, 2021
CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP Inhibition
Mitchell G Lawrence, Laura H Porter, Nicholas Choo, et al.
The EMBO Journal
|
September 18, 2020
Reprogrammed mRNA translation drives resistance to therapeutic targeting of ribosome biogenesis
Eric P Kusnadi, Anna S Trigos, Carleen Cullinane, et al.
Nature Communications
|
May 15, 2023
Spatial analysis with SPIAT and spaSim to characterize and simulate tissue microenvironments
Yuzhou Feng, Tianpei Yang, John Zhu, et al.
Science Signaling
|
August 20, 2015
The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma
Rachel Ramsdale, Robert N Jorissen, Frederic Z Li, et al.
Cancer Discovery
|
December 18, 2012
The mTORC1 inhibitor everolimus prevents and treats Eμ-Myc lymphoma by restoring oncogene-induced senescence
Meaghan Wall, Gretchen Poortinga, Kym L Stanley, et al.
Pigment Cell & Melanoma Research
|
February 6, 2014
Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines
Richard J Young, Kelly Waldeck, Claire Martin, et al.
Science Signaling
|
September 1, 2011
AKT promotes rRNA synthesis and cooperates with c-MYC to stimulate ribosome biogenesis in cancer
Joanna C Chan, Katherine M Hannan, Kim Riddell, et al.
Arthritis and Rheumatism
|
November 30, 2006
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma
Rachel K Hoyles, Ross W Ellis, Jessica Wellsbury, et al.
Page
of 58
Search research articles
Search
Showing results (391-400 of 578) with videos related to
Sort By:
Page
of 58
Cells
|
April 26, 2024
Development and Characterisation of a New Patient-Derived Xenograft Model of AR-Negative Metastatic Castration-Resistant Prostate Cancer
Daniel J Turnham, Manisha S Mullen, Nicholas P Bullock, et al.
Oncotarget
|
October 27, 2017
[10]-gingerol induces apoptosis and inhibits metastatic dissemination of triple negative breast cancer <i>in vivo</i>
Ana Carolina B M Martin, Angelina M Fuzer, Amanda B Becceneri, et al.
Molecular Cancer Therapeutics
|
August 20, 2021
CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP Inhibition
Mitchell G Lawrence, Laura H Porter, Nicholas Choo, et al.
The EMBO Journal
|
September 18, 2020
Reprogrammed mRNA translation drives resistance to therapeutic targeting of ribosome biogenesis
Eric P Kusnadi, Anna S Trigos, Carleen Cullinane, et al.
Nature Communications
|
May 15, 2023
Spatial analysis with SPIAT and spaSim to characterize and simulate tissue microenvironments
Yuzhou Feng, Tianpei Yang, John Zhu, et al.
Science Signaling
|
August 20, 2015
The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma
Rachel Ramsdale, Robert N Jorissen, Frederic Z Li, et al.
Cancer Discovery
|
December 18, 2012
The mTORC1 inhibitor everolimus prevents and treats Eμ-Myc lymphoma by restoring oncogene-induced senescence
Meaghan Wall, Gretchen Poortinga, Kym L Stanley, et al.
Pigment Cell & Melanoma Research
|
February 6, 2014
Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines
Richard J Young, Kelly Waldeck, Claire Martin, et al.
Science Signaling
|
September 1, 2011
AKT promotes rRNA synthesis and cooperates with c-MYC to stimulate ribosome biogenesis in cancer
Joanna C Chan, Katherine M Hannan, Kim Riddell, et al.
Arthritis and Rheumatism
|
November 30, 2006
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma
Rachel K Hoyles, Ross W Ellis, Jessica Wellsbury, et al.
Page
of 58